Bethany Sensenig - Oct 1, 2025 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Director
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
Oct 1, 2025
Transactions value $
$0
Form type
3
Date filed
10/2/2025, 06:27 PM
Previous filing
Aug 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sensenig Bethany Director C/O KALVISTA PHARMACEUTICALS, INC., 200 CROSSING BOULEVARD, FRAMINGHAM /s/ Benjamin L. Palleiko, Attorney-in-Fact 2025-10-02 0001899935

No securities are beneficially owned.